Showing results (51-60 of 52) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
The Lancet. Oncology|January 27, 2022
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trialMin Yan, Quchang Ouyang, Tao Sun, et al.Eclinicalmedicine|October 9, 2024
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trialMin Yan, Quchang Ouyang, Tao Sun, et al.Pageof 6